关注
David Kudlowitz
David Kudlowitz
未知所在单位机构
在 nyumc.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
An artificial intelligence system for predicting the deterioration of COVID-19 patients in the emergency department
FE Shamout, Y Shen, N Wu, A Kaku, J Park, T Makino, S Jastrzębski, ...
NPJ digital medicine 4 (1), 80, 2021
1282021
Defining risks of taxane neuropathy: insights from randomized clinical trials
D Kudlowitz, F Muggia
Clinical Cancer Research 19 (17), 4570-4577, 2013
682013
A validated, real-time prediction model for favorable outcomes in hospitalized COVID-19 patients
N Razavian, VJ Major, M Sudarshan, J Burk-Rafel, P Stella, H Randhawa, ...
NPJ digital medicine 3 (1), 130, 2020
672020
Novel taxanes
F Muggia, D Kudlowitz
Anti-cancer drugs 25 (5), 593-598, 2014
372014
Nanoparticle albumin-bound paclitaxel (nab-paclitaxel): extending its indications
D Kudlowitz, F Muggia
Expert opinion on drug safety 13 (6), 681-685, 2014
242014
Clinical features of taxane neuropathy
D Kudlowitz, F Muggia
Anti-cancer drugs 25 (5), 495-501, 2014
172014
Early recognition of renal toxicity of high-dose methotrexate therapy: a case report
TS Nowicki, K Bjornard, D Kudlowitz, C Sandoval, S Jayabose
Journal of Pediatric Hematology/Oncology 30 (12), 950-952, 2008
172008
Development and validation of a machine learning model for automated assessment of resident clinical reasoning documentation
V Schaye, B Guzman, J Burk-Rafel, M Marin, I Reinstein, D Kudlowitz, ...
Journal of General Internal Medicine 37 (9), 2230-2238, 2022
72022
Development of a clinical reasoning documentation assessment tool for resident and fellow admission notes: a shared mental model for feedback
V Schaye, L Miller, D Kudlowitz, J Chun, J Burk-Rafel, P Cocks, ...
Journal of General Internal Medicine 37 (3), 507-512, 2022
72022
A validated, real-time prediction model for favorable outcomes in hospitalized COVID-19 patients. npj Digit. Med. 3, 130
N Razavian, VJ Major, M Sudarshan, J Burk-Rafel, P Stella, H Randhawa, ...
62020
Acute leukemias following a diagnosis of colorectal cancer: Are they therapy-related?
EM Stein, V Pareek, D Kudlowitz, D Douer, MS Tallman
Blood 120 (21), 1453, 2012
52012
An artificial intelligence system for predicting the deterioration of COVID-19 patients in the emergency department (preprint)
FE Shamout, Y Shen, N Wu, A Kaku, J Park, T Makino, S Jastrzębski, ...
32020
Carboplatin (every 21 days) and divided-dose paclitaxel (days 1, 11): rationale and tolerance in chemotherapy naïve women with high-grade epithelial cancers of Mullerian origin
D Kudlowitz, A Velastegui, F Musa, F Muggia
Cancer Chemotherapy and Pharmacology 81, 847-851, 2018
22018
Clinical and laboratory characteristics associated with a high optical density anti-platelet factor 4 ELISA test
BY Lu, D Kudlowitz, LB Gardner
Journal of Blood Medicine, 277-283, 2015
22015
Hickam’s dictum, Occam’s razor, and Crabtree’s bludgeon: a case of renal failure and a clavicular mass
S Blaser, V Schaye, J Hwang, P Cocks, D Kudlowitz
Diagnosis 9 (1), 133-139, 2022
12022
Integrating targeted drugs with taxanes and platinums: opportunities and challenges
D Kudlowitz, E Teplinsky, F Muggia
Translational Cancer Research 4 (1), 2015
12015
Lessons in clinical reasoning‒pitfalls, myths and pearls: a case of recurrent pancreatitis
V Jaspan, V Schaye, AS Parsons, D Kudlowitz
Diagnosis 9 (2), 288-293, 2022
2022
NOTESENSE: DEVELOPMENT OF A MACHINE LEARNING ALGORITHM FOR FEEDBACK ON CLINICAL REASONING DOCUMENTATION
V Schaye, B Guzman, JB Rafel, D Kudlowitz, I Reinstein, L Miller, P Cocks, ...
JOURNAL OF GENERAL INTERNAL MEDICINE 36 (SUPPL 1), S110-S110, 2021
2021
An artificial intelligence system for predicting the deterioration of COVID-19 patients in the emergency
FE Shamout, Y Shen, N Wu, A Kaku, J Park, T Makino, S Jastrzebski, ...
arXiv preprint arXiv:2008.01774, 2020
2020
Platinum type is key in determining degree of neuropathy
F Muggia, D Kudlowitz
Gynecologic oncology reports 26, 32, 2018
2018
系统目前无法执行此操作,请稍后再试。
文章 1–20